{"id":"W1971512067","doi":"10.1016/j.jcf.2013.12.009","title":"A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis","year":2014,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"ca_institutions":"Boehringer Ingelheim (Canada); McGill University Health Centre; Montreal Children's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Cystic Fibrosis Foundation","keywords":"Cystic fibrosis; Medicine; Placebo; Double blind; Antagonist; Lung disease; Receptor antagonist; Internal medicine; Lung; Randomized controlled trial; Gastroenterology; Receptor; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001799299,0.002498348,0.005548717,0.0007330924,0.0006989314,0.001301701,0.00158079,0.003033126,0.01321658],"category_scores_gemma":[0.002064675,0.001388377,0.001659501,0.0004704947,0.001693994,0.001754741,0.0006644261,0.00449746,0.002304719],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007839156,"about_ca_system_score_gemma":0.001632678,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001594344,"about_ca_topic_score_gemma":0.003372504,"domain_scores_codex":[0.9993113,0.0003110193,0.00004537108,0.0001396935,0.00005200064,0.000140509],"domain_scores_gemma":[0.9991307,0.0002268021,0.0001418219,0.00007639419,0.00007138108,0.0003529793],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.988294,0.004529194,0.00009841291,0.0003429673,0.0003391428,0.00002145823,0.00002303626,0.0001093526,0.001584102,0.00008395743,0.0005617577,0.004012517],"study_design_scores_gemma":[0.9846596,0.01450456,0.0002652879,0.000008844963,0.0001045422,0.000008594558,0.000007039442,0.00008981205,0.00009182823,0.0000410838,0.0002125011,0.000006409522],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9617032,0.006465398,0.002051394,0.001995048,0.002461608,0.0159165,0.00363463,0.0006274196,0.005144772],"genre_scores_gemma":[0.94556,0.005434432,0.004738574,0.00429642,0.001201097,0.02388946,0.003400774,0.0001238723,0.01135539],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01321658,"threshold_uncertainty_score":0.04421389,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0121357020093496,"score_gpt":0.3139832868791729,"score_spread":0.3018475848698233,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}